Zimbabwe has rejected a significant US health deal worth $367m (£272m) spanning five years due to the United States' demand for sensitive biological samples.
This move was revealed following a internal memorandum from December was leaked, indicating that President Emmerson Mnangagwa deemed the agreement was "unbalanced".
A government spokesperson has since explained that the US was seeking biological samples for scientific study and commercial purposes but was not willing to share the benefits from any future treatments.
"We will now turn to the difficult and regrettable process of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had donated over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has urged continued talks to find a deal agreeable to both sides so the country's vital HIV treatment initiative can proceed.
Broader Implications
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a high court halted a similar deal with the US after legal challenges were raised about the safety of Kenyans' health data.
After returning to office last year, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
The agency had managed assistance for the US government, but Trump claimed its expenditure was "wasteful" and his administration was seeking direct bilateral deals to enhance transparency and responsibility.
Based on reports, 16 nations in Africa have so far signed similar health pacts, constituting more than $18.3bn in committed funds.
Details of the Rejected Deal
This assistance for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this collaboration might have yielded immense benefits for the people of Zimbabwe, particularly the 1.2 million currently on antiretroviral therapy through American-funded programmes," the Ambassador said.
However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".
"Our nation was requested to provide its genetic material and health information indefinitely, without any equivalent promise of benefiting from any medical innovations – such as new medicines or tests – that might result from that provided information," his statement read.
"Put simply, our nation would provide the raw materials for scientific discovery without any assurance that the end products would be accessible to our citizens should a future health crisis arise."
National Interest and Global Health
He also said that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were undermining frameworks already set up through the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to manage future global health emergencies.
"This framework is intended to ensure that when a nation contributes its samples, the benefits – including medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to develop them."
These objections over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We welcome further dialogue with our US partners on how subsequent co-operation could be arranged in a manner that honours the independence and interests of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but recommended that talks need to persist considering a large portion of the country's HIV programmes were funded by international support.
"In cases where technical issues exist, including those relating to information security or agreement terms, these can often be resolved via detailed discussion and mutually agreed protections," the group added.
The halted deal underscores the complex tensions between accepting vital international aid and safeguarding local interests in an ever more interconnected world.